Product Information
TOVET EMOLLIENT 0.05% FOAM is a generic product labeled by Medimetriks Pharmaceuticals Inc., priced at $1.7892 per GM under NDC 43538095210. Its NADAC has been published 285 times since May 20, 2020.
FDA first approved this application on Aug 14, 2012. Its Orange Book therapeutic-equivalence code is AB2 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the CLOBETASOL PROPIONATE market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
.5 mg/g
Manufacturer
Medimetriks Pharmaceuticals Inc.NDC
43538095210
Classification
Generic
Dosage Form
AEROSOL, FOAM
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
CLOBETASOL PROPIONATEApproval Type
Generic (ANDA)
FDA Application
ANDA201402FDA Approved
8/14/2012
TE Code
AB2
On Market Since
2/1/2013
Pharmacological Classes
Price Statistics
The NADAC for TOVET EMOLLIENT 0.05% FOAM has been published 285 times since May 20, 2020, and over the history we have for it it has declined 45.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.7892 per GM |
|---|---|
| All-time high | $3.2827 (May 12, 2021) |
| All-time low | $0.8672 (Aug 21, 2024) |
| 52-week high | $2.5158 |
| 52-week low | $1.7892 |
| Median price | $2.3884 |
| Average price | $2.3365 |
| Largest weekly change | +35.3% (Feb 18, 2026) |
| Weeks tracked | 285 |
| Tracking since | May 20, 2020 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the CLOBETASOL PROPIONATE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Medimetriks Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
CLOBETASOL PROPIONATE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TOVET EMOLLIENT 0.05% FOAM?
The current National Average Drug Acquisition Cost (NADAC) for TOVET EMOLLIENT 0.05% FOAM, manufactured by Medimetriks Pharmaceuticals Inc., is $1.7892 per GM (NDC 43538095210), effective Sep 30, 2026.
How has the price of TOVET EMOLLIENT 0.05% FOAM changed over time?
Over the history we have for it, the NADAC for TOVET EMOLLIENT 0.05% FOAM has declined 45.5%. It has been tracked across 285 weekly CMS publications since May 20, 2020.
What are the highest and lowest recorded NADAC prices for TOVET EMOLLIENT 0.05% FOAM?
Since May 20, 2020, the NADAC for TOVET EMOLLIENT 0.05% FOAM has ranged from a low of $0.8672 (Aug 21, 2024) to a high of $3.2827 (May 12, 2021), with a median of $2.3884 per GM.
Are there cheaper alternatives to TOVET EMOLLIENT 0.05% FOAM?
No other NADAC-published product currently shares the active ingredient and strength of TOVET EMOLLIENT 0.05% FOAM in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures TOVET EMOLLIENT 0.05% FOAM?
TOVET EMOLLIENT 0.05% FOAM (NDC 43538095210) is labeled by Medimetriks Pharmaceuticals Inc., and CMS classifies it as a generic product.